B7-H4 overexpression in ovarian tumors (Q38440378)

3 September 2017

title

B7-H4 overexpression in ovarian tumors (English)

1 reference

3 September 2017

1 reference

5

Takayuki Enomoto

1 reference

3 September 2017

Barbara Tringler

1

1 reference

3 September 2017

Wenhui Liu

2

1 reference

3 September 2017

Laura Corral

3

1 reference

3 September 2017

Kathleen C Torkko

4

1 reference

3 September 2017

Susan Davidson

6

1 reference

3 September 2017

M Scott Lucia

7

1 reference

3 September 2017

David E Heinz

8

1 reference

3 September 2017

Jackie Papkoff

9

1 reference

3 September 2017

Kenneth R Shroyer

10

1 reference

3 September 2017

language of work or name

English

0 references

publication date

26 October 2005

1 reference

3 September 2017

1 reference

3 September 2017

volume

100

1 reference

3 September 2017

issue

1

1 reference

3 September 2017

page(s)

44-52

1 reference

Survival of patients with epithelial ovarian cancer and the effect of lymphadenectomy in those with stage 3 disease

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2005.08.060

Moderate progress for ovarian cancer in the last 20 years: prolongation of survival, but no improvement in the cure rate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2005.08.060

Evaluation of monoclonal humanized anti-HER2 antibody, trastuzumab, in patients with recurrent or refractory ovarian or primary peritoneal carcinoma with overexpression of HER2: a phase II trial of the Gynecologic Oncology Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2005.08.060

BTLA: a new inhibitory receptor with a B7-like ligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2005.08.060

B7-H4, a molecule of the B7 family, negatively regulates T cell immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2005.08.060

B7S1, a novel B7 family member that negatively regulates T cell activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2005.08.060

Co-signaling molecules of the B7-CD28 family in positive and negative regulation of T lymphocyte responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2005.08.060

The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2005.08.060

B7-h4 is highly expressed in ductal and lobular breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2005.08.060

Prognosis of 2,800 patients with epithelial ovarian cancer diagnosed during 1975-94 and treated at the Norwegian Radium Hospital

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2005.08.060

Surgical management of advanced ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2005.08.060

Current Status of Taxane and Platinum-Based Chemotherapy in Ovarian Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2005.08.060

Carboplatin and paclitaxel in ovarian carcinoma: a phase I study of the Gynecologic Oncology Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2005.08.060

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2005.08.060

Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2005.08.060

Clinically apparent early stage invasive epithelial ovarian carcinoma: should all be treated similarly?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2005.08.060

Application of Mesothelin Immunostaining in Tumor Diagnosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2005.08.060

Expression of E-cadherin and N-cadherin in surface epithelial-stromal tumors of the ovary distinguishes mucinous from serous and endometrioid tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2005.08.060

Genomic Organization and Expression Analysis of B7-H4, an Immune Inhibitory Molecule of the B7 Family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2005.08.060

Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2005.08.060

10.1016/J.YGYNO.2005.08.060

7 January 2021

Identifiers

DOI

1 reference

3 September 2017

1 reference